
Suzanne Marie Noakes
Examiner (ID: 17824)
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1656, 1653 |
| Total Applications | 1691 |
| Issued Applications | 1090 |
| Pending Applications | 193 |
| Abandoned Applications | 452 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5533478
[patent_doc_number] => 20090233266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'STRUCTURE OF THE HEPATITIS C VIRUS NS2 PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 11/817782
[patent_app_country] => US
[patent_app_date] => 2006-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14926
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20090233266.pdf
[firstpage_image] =>[orig_patent_app_number] => 11817782
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/817782 | STRUCTURE OF THE HEPATITIS C VIRUS NS2 PROTEIN | Mar 8, 2006 | Abandoned |
Array
(
[id] => 274063
[patent_doc_number] => 07560227
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-14
[patent_title] => 'Biomarkers of vulnerable atherosclerotic plaques and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/365127
[patent_app_country] => US
[patent_app_date] => 2006-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 16
[patent_no_of_words] => 9435
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/560/07560227.pdf
[firstpage_image] =>[orig_patent_app_number] => 11365127
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/365127 | Biomarkers of vulnerable atherosclerotic plaques and methods of use | Feb 27, 2006 | Issued |
Array
(
[id] => 4461103
[patent_doc_number] => 07894996
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-22
[patent_title] => 'Structure of the hepatitis C NS5A protein'
[patent_app_type] => utility
[patent_app_number] => 11/817309
[patent_app_country] => US
[patent_app_date] => 2006-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 20
[patent_no_of_words] => 18550
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/894/07894996.pdf
[firstpage_image] =>[orig_patent_app_number] => 11817309
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/817309 | Structure of the hepatitis C NS5A protein | Feb 27, 2006 | Issued |
Array
(
[id] => 4964846
[patent_doc_number] => 20080107666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'Non-Glycosylated Recombinant Collagen-Like Polypeptides'
[patent_app_type] => utility
[patent_app_number] => 11/817006
[patent_app_country] => US
[patent_app_date] => 2006-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6816
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20080107666.pdf
[firstpage_image] =>[orig_patent_app_number] => 11817006
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/817006 | Non-glycosylated recombinant collagen-like polypeptides | Feb 21, 2006 | Issued |
Array
(
[id] => 5625866
[patent_doc_number] => 20060264371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Treatment'
[patent_app_type] => utility
[patent_app_number] => 11/356453
[patent_app_country] => US
[patent_app_date] => 2006-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8096
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20060264371.pdf
[firstpage_image] =>[orig_patent_app_number] => 11356453
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/356453 | Treatment | Feb 16, 2006 | Abandoned |
Array
(
[id] => 4840325
[patent_doc_number] => 20080280811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-13
[patent_title] => 'Compositions and Methods for Treating Vascular Permeability'
[patent_app_type] => utility
[patent_app_number] => 11/884503
[patent_app_country] => US
[patent_app_date] => 2006-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17436
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20080280811.pdf
[firstpage_image] =>[orig_patent_app_number] => 11884503
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/884503 | Compositions and methods for treating vascular permeability | Feb 15, 2006 | Issued |
Array
(
[id] => 4887544
[patent_doc_number] => 20080261876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Method for Purifying Marine Collagen and the Processing Thereof Into Porous Sponges'
[patent_app_type] => utility
[patent_app_number] => 11/817044
[patent_app_country] => US
[patent_app_date] => 2006-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2026
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20080261876.pdf
[firstpage_image] =>[orig_patent_app_number] => 11817044
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/817044 | Method for purifying marine collagen and the processing thereof into porous sponges | Feb 13, 2006 | Issued |
Array
(
[id] => 5700621
[patent_doc_number] => 20060217306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Systemic treatment of infections with defensins'
[patent_app_type] => utility
[patent_app_number] => 11/350321
[patent_app_country] => US
[patent_app_date] => 2006-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5927
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20060217306.pdf
[firstpage_image] =>[orig_patent_app_number] => 11350321
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/350321 | Systemic treatment of infections with defensins | Feb 7, 2006 | Abandoned |
Array
(
[id] => 283411
[patent_doc_number] => 07555415
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-30
[patent_title] => 'Methods for the design of estrogen receptor ligands'
[patent_app_type] => utility
[patent_app_number] => 11/334982
[patent_app_country] => US
[patent_app_date] => 2006-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 142818
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 324
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/555/07555415.pdf
[firstpage_image] =>[orig_patent_app_number] => 11334982
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/334982 | Methods for the design of estrogen receptor ligands | Jan 17, 2006 | Issued |
Array
(
[id] => 5655785
[patent_doc_number] => 20060141520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Methods for the treatment of metabolic disorders, including obesity and diabetes'
[patent_app_type] => utility
[patent_app_number] => 11/331549
[patent_app_country] => US
[patent_app_date] => 2006-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 29490
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20060141520.pdf
[firstpage_image] =>[orig_patent_app_number] => 11331549
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/331549 | Methods for the treatment of metabolic disorders, including obesity and diabetes | Jan 12, 2006 | Abandoned |
Array
(
[id] => 5733728
[patent_doc_number] => 20060258845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Novel purified polypeptides from Staphylococcus aureus'
[patent_app_type] => utility
[patent_app_number] => 11/329987
[patent_app_country] => US
[patent_app_date] => 2006-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 169
[patent_figures_cnt] => 169
[patent_no_of_words] => 72478
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11329987
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/329987 | Purified polypeptides from Staphylococcus aureus | Jan 10, 2006 | Issued |
Array
(
[id] => 4994577
[patent_doc_number] => 20070009922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-11
[patent_title] => 'Hot start polymerase reaction using a thermolabile blocker'
[patent_app_type] => utility
[patent_app_number] => 11/324887
[patent_app_country] => US
[patent_app_date] => 2006-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16274
[patent_no_of_claims] => 83
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20070009922.pdf
[firstpage_image] =>[orig_patent_app_number] => 11324887
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/324887 | Hot start polymerase reaction using a thermolabile blocker | Jan 3, 2006 | Abandoned |
Array
(
[id] => 6352086
[patent_doc_number] => 20100021987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'Compositions, Methods, and Kits for Enhancing Protein Expression'
[patent_app_type] => utility
[patent_app_number] => 11/794532
[patent_app_country] => US
[patent_app_date] => 2005-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 22067
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20100021987.pdf
[firstpage_image] =>[orig_patent_app_number] => 11794532
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/794532 | Human SUMO-3 for enhancing protein expression | Dec 29, 2005 | Issued |
Array
(
[id] => 5672078
[patent_doc_number] => 20060177432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Methods and reagents for protease inhibition'
[patent_app_type] => utility
[patent_app_number] => 11/311974
[patent_app_country] => US
[patent_app_date] => 2005-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11775
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20060177432.pdf
[firstpage_image] =>[orig_patent_app_number] => 11311974
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/311974 | Methods and reagents for protease inhibition | Dec 18, 2005 | Abandoned |
Array
(
[id] => 239126
[patent_doc_number] => 07591841
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-22
[patent_title] => 'Implantable devices for accelerated healing'
[patent_app_type] => utility
[patent_app_number] => 11/303724
[patent_app_country] => US
[patent_app_date] => 2005-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5074
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/591/07591841.pdf
[firstpage_image] =>[orig_patent_app_number] => 11303724
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/303724 | Implantable devices for accelerated healing | Dec 15, 2005 | Issued |
Array
(
[id] => 197068
[patent_doc_number] => 07638599
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-29
[patent_title] => 'Conjugates of membrane translocating agents and pharmaceutically active agents'
[patent_app_type] => utility
[patent_app_number] => 11/303372
[patent_app_country] => US
[patent_app_date] => 2005-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17297
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/638/07638599.pdf
[firstpage_image] =>[orig_patent_app_number] => 11303372
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/303372 | Conjugates of membrane translocating agents and pharmaceutically active agents | Dec 15, 2005 | Issued |
Array
(
[id] => 5678327
[patent_doc_number] => 20060183683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Liquid composition of factor VII polypeptides'
[patent_app_type] => utility
[patent_app_number] => 11/304429
[patent_app_country] => US
[patent_app_date] => 2005-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12514
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20060183683.pdf
[firstpage_image] =>[orig_patent_app_number] => 11304429
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/304429 | Liquid composition of factor VII polypeptides | Dec 14, 2005 | Abandoned |
Array
(
[id] => 6622805
[patent_doc_number] => 20100003709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'Crystal Structure of Enzyme and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/793367
[patent_app_country] => US
[patent_app_date] => 2005-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 112795
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20100003709.pdf
[firstpage_image] =>[orig_patent_app_number] => 11793367
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/793367 | Crystal Structure of Enzyme and Uses Thereof | Dec 12, 2005 | Abandoned |
Array
(
[id] => 5563723
[patent_doc_number] => 20090136575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'Protein Formulation'
[patent_app_type] => utility
[patent_app_number] => 11/721192
[patent_app_country] => US
[patent_app_date] => 2005-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 24489
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20090136575.pdf
[firstpage_image] =>[orig_patent_app_number] => 11721192
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/721192 | Protein formulation | Dec 11, 2005 | Issued |
Array
(
[id] => 5834641
[patent_doc_number] => 20060246471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Compositions and methods for screening pro-apoptotic compounds'
[patent_app_type] => utility
[patent_app_number] => 11/299139
[patent_app_country] => US
[patent_app_date] => 2005-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 36666
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20060246471.pdf
[firstpage_image] =>[orig_patent_app_number] => 11299139
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/299139 | Compositions and methods for screening pro-apoptotic compounds | Dec 8, 2005 | Abandoned |